Bristol-myers Company

Minoru Hanada

Masataka Konishi

Koji Tomita

Hiroshi Tsukiura

Yuji Nishiyama

Hiroshi Kawaguchi

Mitsuaki Tsunakawa

Seikichi Kobaru

The antibiotic designated BU-4061T is produced by fermentation of actinomycete strain Q996-17 (ATCC-53904). The BU-4061T antibiotic exhibits both in vitro and in vivo antitumor activity.

Antibiotic BU-4061T

A new antibiotic designated BU-4061T is produced by fermentation of actinomycete strain Q996-17 (ATCC-53904). The BU-4061T antibiotic exhibits both in vitro and in vivo antitumor activity.

Bu-4061T

Antibiotic Bu-2659 complex, containing components A, B, C, D and E, is produced by cultivation of Streptomyces hygroscopicus Strain No. J296-21, ATCC No. 39150.

Antibiotics produced by fermentation of a novel strain of Streptomyces

A fermentation process for preparing capreomycin, a known antibiotic, employing a heretofore unknown microorganism is described, said microorganism being classified as a member of the genus Dactylosporangium and being herein named Dactylosporangium variesporum strain D409-5 (ATCC 31203).

Growing community of inventors

Tokyo, Japan

Minoru Hanada